
|Videos|February 7, 2021
Emerging therapies in management of AMD
Author(s)OT Staff Reports
Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.
Advertisement
Anat Loewenstein, MD, chair, Department of Ophthalmology, Tel Aviv Medical Center (Israel), provides an update on the latest developments in emerging therapies for the management of age-related macular d
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
2
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
4
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
5




















